
Latham & Watkins has added regulatory experience to its antitrust and competition practice in Washington, DC, in the form of a former acting deputy director of the Federal Trade Commission.
A former acting deputy director of the US Federal Trade Commission (FTC) has returned to Latham & Watkins for a third spell. Alan Devlin has joined the litigation and trial department of the global antitrust and competition practice as counsel in Washington, DC, after leaving the FTC last month.
Devlin spent two years with the agency, initially as an attorney advisor to acting chairman Maureen Ohlhausen, then as acting deputy director of the bureau of competition.
His first spell at the firm came at the beginning of his career, with two years as an associate in the Chicago office. After a couple of years working as a judicial clerk and lecturer, he returned to the firm for three-and-a-half years, this time in San Francisco, before joining the FTC in August 2015.
Devlin works on cases relating to merger control, appeals and intellectual property (IP) disputes. He brings valuable first-hand experience of the regulatory regime at a time when the number of antitrust cases continues to grow, driven by increased regulation around the world.
Full Content: WIPR
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas